|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy and Safety of a novel cholesteryl ester transfer protein inhibitor,JTT-705,in humans:a randomized phase dose-response study显示文摘 | de Grooth GJ Kuivenhoven JA Stalenhoef AF | 2002 | Circulation2002，105，18： | 1 |
| 2 | Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type Ⅱ dyslipidemia显示文摘 | Kuivenhoven JA de Grooth GJ Kawamura H | 2005 | Am J Cardiol2005，95，9： | 1 |
| 3 | A review of CETP and its relation to atherosclerosis显示文摘 | de Grooth GJ Klerkx AHEM Stroes ESG Stalenhoef AFH Kastelein JJP Kuivenhoven JA | 2004 | J Lipid Res2004，45，11： | 1 |
| 4 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor,JTT-705,in humans:a randomized phase Ⅱ dose-response study显示文摘 | de Grooth GJ Kuivenhoven JA Stalenhoef AF | 2002 | Circulation2002，105，18： | 1 |
| 5 | The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia显示文摘 | de Grooth GJ Smilde TJ Van Wissen S Klerkx AH Zwinderman AH | 2004 | Atherosclerosis2004，173，2： | 1 |
| 6 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor,JTT-705,in humans:a randomized phaseⅡdoseresponse study显示文摘 | Kuivenhoven JA Stalenhoef AF | 2002 | Circulation2002，105，18： | 1 |
| 7 | Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in typeⅡdyslipidemia显示文摘 | de Grooth GJ Kawamura H | 2005 | Am J Cardiol2005，95，9： | 1 |
| 8 | The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia 显示文摘 | de GROOTH GJ SMILDE T J van WISSEN S | 2004 | Atherosclerosis2004，173，2： | 1 |
| 9 | A review of CETP and its relation to atherosclerosis 显示文摘 | de Grooth GJ Klerkx AH Stroes ES | 2004 | J Lipid Res2004，45，11： | 1 |
| 10 | Efficacy and safety of a novel chotesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase Ⅱ doseresponse study显示文摘 | de GROOTH GJ KUIVENHOVEN JA STALENHOEF AF | 2002 | Circulation2002，105，18： | 1 |
| 11 | Inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type Ⅱ dyslipidemia显示文摘 | KUIVENHOVEN JA de GROOTH GJ KAWAMURA H | 2005 | Am J Cardiol2005，95，9： | 1 |
| 12 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase Ⅱ dose-response study显示文摘 | de GROOTH GJ KUIVENHOVEN JA STALENHOEF AF | 2002 | Circulation2002，105，18： | 1 |
| 13 | Inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type Ⅱ dyslipidemia显示文摘 | KUIVENHOVEN JA de GROOTH GJ KAWAMURA H | 2005 | Am J Cardiol2005，95，9： | 1 |
| 14 | Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type Ⅱ dyslipidemia显示文摘 | Kuivenhoven JA de Grooth GJ Kawamura H | 2005 | Am J Cardiol2005，95，： | 1 |
| 15 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor,JTT-705,in humans:a randomized phase Ⅱ dose-response study显示文摘 | de Grooth GJ Kuivenhoven JA Stalenhoef AF de Graaf J Zwinderman AH Posma JL | 2002 | Circulation2002，105，： | 1 |
| 16 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705 ,in humans:a randomized phase Ⅱ dose-response study显示文摘 | Kuivenhoven JA Stalenhoef AF | 2002 | Circulation2002，105，18： | 1 |
| 17 | A review of CETP and its relation to atherosclerosis显示文摘 | de Grooth GJ Klerkx AH Stroes ES | 2004 | J Lipid Res2004，45，： | 1 |
| 18 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705,in humans: a randomized phase Ⅱ doee-response study显示文摘 | de Grooth GJ Kuivenhoven JA Stalenhoef AF | 2002 | Circulation2002，105，18： | 1 |
| 19 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase Ⅱ dose-response study显示文摘 | de GROOTH GJ KUIVENHOVEN JA STALENHOEF AF | 2002 | Circulation2002，105，18： | 1 |
| 20 | The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study:no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome:a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy显示文摘 | de Grooth GJ Zerba KE Huang SP | 2004 | J Am Coll Cardiol2004，43，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员